| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 11/02/2006 | EP1716100A2 Therapeutic amide derivatives |
| 11/02/2006 | EP1401801B1 Selective androgen receptor modulators and methods of use thereof |
| 11/02/2006 | EP0999209B1 2-sulfamoylbenzoic acid derivatives |
| 11/02/2006 | CA2605480A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
| 11/02/2006 | CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 11/01/2006 | CN1856471A A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
| 11/01/2006 | CN1856470A 喹啉钾通道抑制剂 Quinoline potassium channel inhibitors |
| 11/01/2006 | CN1856465A Amino-substituted ethylamino beta2 adrenergic receptor agonists |
| 11/01/2006 | CN1856307A Quinoline potassium channel inhibitors |
| 11/01/2006 | CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 11/01/2006 | CN1282641C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 10/31/2006 | US7129518 organometallic iridium complexes used as light emitting layers in organic light emitting diodes, having layers of charge transfer compounds |
| 10/31/2006 | US7129357 Cyclization; solvent extraction; hydrolysis; phosphodiesterase (PDE IV) inhibitors |
| 10/31/2006 | US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 10/31/2006 | US7129249 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 10/31/2006 | US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 10/31/2006 | US7129093 Quantitative method of determining beryllium or a compound thereof in a sample |
| 10/31/2006 | CA2349663C Quinolinone derivative formulation and its production method |
| 10/31/2006 | CA2246126C New piperazine compounds |
| 10/31/2006 | CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 10/26/2006 | WO2006112225A1 Organic el material, organic el element employing the same, and process for producing organic el element |
| 10/26/2006 | WO2006111716A1 Heteroaryl derivatives having anti-mycobacterial activity |
| 10/26/2006 | WO2006094237A3 Acridine and quinoline dervatives as sirtuin modulators |
| 10/26/2006 | WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 10/26/2006 | WO2006008751A3 Process for the preparation of montelukast and its salts |
| 10/26/2006 | US20060241155 TNF-alpha production inhibitors |
| 10/26/2006 | US20060241129 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 10/26/2006 | US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 10/26/2006 | DE102005018026A1 New substituted styrol stereoisomers are glucocorticoid receptor ligands useful for the treatment of e.g. inflammatory diseases, lung diseases, rheumatic diseases, autoimmune diseases, joint disorders and gastrointestinal disorders |
| 10/26/2006 | CA2604787A1 Quinobenzoxazine analogs and methods of using thereof |
| 10/25/2006 | EP1714958A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide |
| 10/25/2006 | EP1713823A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713822A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713803A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
| 10/25/2006 | EP1713776A1 Quinoline derivatives for use as mycobacterial inhibitors |
| 10/25/2006 | EP1713757A2 Hydroaminomethylation of olefins |
| 10/25/2006 | EP1713750A1 Method for preparation of a fluoroarmatic compound from an aminoaromatic amine compound |
| 10/25/2006 | EP1713484A2 Compounds and methods of use |
| 10/25/2006 | EP1458718B1 Quinolinones as prostaglandin receptor ligands |
| 10/25/2006 | CN1852896A Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 10/25/2006 | CN1852895A 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents |
| 10/25/2006 | CN1852713A Polymorphic form of montelukast sodium |
| 10/25/2006 | CN1850817A Roofirisrhizome flavin non polar isostere, and its preparing method and use |
| 10/25/2006 | CN1281585C Cyclic diamine compounds having fused-ring groups |
| 10/24/2006 | US7126025 intermediates in the synthesis of pharmaceutically active protein kinase inhibitors |
| 10/24/2006 | US7126001 Antiproliferative agents; antitumor agents |
| 10/24/2006 | US7125892 Aryl aniline β2 adrenergic receptor agonists |
| 10/19/2006 | WO2006110668A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 10/19/2006 | WO2006110516A1 Acylhydrazide p2x7 antagonists and uses thereof |
| 10/19/2006 | WO2006109085A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 10/19/2006 | WO2006109084A1 Dna-pk inhibitors |
| 10/19/2006 | WO2006108714A2 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 10/19/2006 | WO2006044107A3 Method of treating human preeclampsia employing resibufagenin |
| 10/19/2006 | WO2006039250A3 Chemokine-binding heterocyclic compound salts, and methods of use thereof |
| 10/19/2006 | US20060235220 Dipeptide nitriles |
| 10/19/2006 | US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders |
| 10/19/2006 | US20060235045 Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same |
| 10/19/2006 | US20060235033 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
| 10/19/2006 | US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/19/2006 | US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same |
| 10/19/2006 | US20060234927 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 10/19/2006 | DE102005017316A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 10/19/2006 | CA2604291A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 10/19/2006 | CA2604042A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 10/18/2006 | EP1712225A1 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
| 10/18/2006 | EP1711468A1 Process for preparing purified ciprofloxacin |
| 10/18/2006 | EP1711467A2 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof |
| 10/18/2006 | EP1711466A1 Process for preparing aripiprazole |
| 10/18/2006 | EP1711181A1 Quinoline derivatives and use thereof as mycobacterial inhibitors |
| 10/18/2006 | EP1711175A1 Diurea derivatives |
| 10/18/2006 | EP1711166A1 Stable amorphous forms of montelukast sodium |
| 10/18/2006 | CN1849330A Specific glucocorticosteroid compound having anti-inflammatory activity |
| 10/18/2006 | CN1849321A Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 10/18/2006 | CN1849299A Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile |
| 10/18/2006 | CN1849117A Entry inhibitors of the HIV virus |
| 10/18/2006 | CN1847226A Quinolyl amide derivative and its prepn process and use |
| 10/18/2006 | CN1847225A Quinoline compound and its prepn process |
| 10/18/2006 | CN1280275C Pyridione derivatives for tretment of atherosclerosis |
| 10/18/2006 | CN1280259C Aryl aniline beta-2 adrenergic receptor agonists |
| 10/17/2006 | US7122677 NK1 antagonists |
| 10/17/2006 | US7122672 N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; treating agricultural and horticultural fungal infections of plants |
| 10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 10/17/2006 | CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists |
| 10/12/2006 | WO2006107035A1 Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element |
| 10/12/2006 | WO2006106778A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | WO2006106727A1 Benzyloxypropylamine derivative |
| 10/12/2006 | WO2006106241A1 Piperazine derivatives and use thereof as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/12/2006 | WO2006073938A3 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| 10/12/2006 | WO2006066879A3 Compounds with kv4 ion channel activity |
| 10/12/2006 | WO2006060225A3 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
| 10/12/2006 | WO2006050239A3 Muscarinic acetylcholine receptor antagonists |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | WO2005095326A8 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
| 10/12/2006 | US20060229451 Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative |
| 10/12/2006 | US20060229342 TNF-a production inhibitors |
| 10/12/2006 | US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 10/12/2006 | US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/12/2006 | US20060229312 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | CA2603030A1 Benzyloxypropylamine derivative |